Hepatic Infarction
(UMLS:C0151731)
- Definition:
- Formation of infarct resulting from obstruction of HEPATIC ARTERY and/or PORTAL VEIN most often after LIVER TRANSPLANTATION or hepatobiliary surgery.
- UMLS ID:
- C0151731
- MeSH ID:
- N/A
Synonym(s)
1.
Hepatic Infarction
2.
HEPATIC INFARCT
3.
HEPATIC INFARCTION
4.
Hepatic infarction
5.
INFARCT OF LIVER
6.
Infarct of liver
7.
Infarction of liver
8.
hepatic infarction
9.
infarction liver
10.
infarction; liver
11.
liver infarction
12.
liver; infarction
Associated Drug(s)
| Name | Number of Reports | Reference(s) | Data Source | |
|---|---|---|---|---|
| 1 | Isotretinoin | FAERS: 8 | US FAERS | |
| 2 | Sorafenib | FAERS: 7 | US FAERS | |
| 3 | Rivaroxaban | FAERS: 3 | US FAERS | |
| 4 | Tacrolimus | FAERS: 3 | US FAERS | |
| 5 | reviparin | FAERS: 3 | US FAERS | |
| 6 | Aprotinin | FAERS: 2 | US FAERS | |
| 7 | Doxorubicin | FAERS: 2 | US FAERS | |
| 8 | Prednisolone | FAERS: 2 | US FAERS | |
| 9 | Acetaminophen | FAERS: 1 | US FAERS | |
| 10 | Afatinib | FAERS: 1 | US FAERS | |
| 11 | Fluorouracil | FAERS: 1 | US FAERS | |
| 12 | Imatinib Mesylate | FAERS: 1 | US FAERS | |
| 13 | Letrozole | FAERS: 1 | US FAERS | |
| 14 | Methamphetamine | FAERS: 1 | US FAERS | |
| 15 | Methylprednisolone | FAERS: 1 | US FAERS | |
| 16 | Mitomycin | FAERS: 1 | US FAERS | |
| 17 | Nafcillin | FAERS: 1 | US FAERS | |
| 18 | Norethindrone | FAERS: 1 | US FAERS | |
| 19 | Oxandrolone | FAERS: 1 | US FAERS | |
| 20 | Sevoflurane | FAERS: 1 | US FAERS | |
| 21 | Sitagliptin Phosphate | FAERS: 1 | US FAERS | |
| 22 | Sulfamethoxazole | FAERS: 1 | OFFSIDES US FAERS | |
| 23 | Tigecycline | FAERS: 1 | US FAERS | |
| 24 | Valproic Acid | FAERS: 1 | US FAERS | |
| 25 | baricitinib | FAERS: 1 | US FAERS | |
| 26 | gemcitabine | FAERS: 1 | US FAERS | |
| 27 | olaparib | FAERS: 1 | US FAERS | |
| 28 | Azithromycin | OFFSIDES | ||
| 29 | Benzoyl Peroxide | OFFSIDES | ||
| 30 | Bortezomib | OFFSIDES | ||
| 31 | Bosentan | OFFSIDES | ||
| 32 | Budesonide | OFFSIDES | ||
| 33 | Bumetanide | OFFSIDES | ||
| 34 | Chlorothiazide | OFFSIDES | ||
| 35 | Cytarabine | OFFSIDES | ||
| 36 | Daunorubicin | OFFSIDES | ||
| 37 | Digoxin | OFFSIDES | ||
| 38 | Dilazep | OFFSIDES | ||
| 39 | Docusate sodium | OFFSIDES | ||
| 40 | Ertapenem | OFFSIDES | ||
| 41 | Fosinopril | OFFSIDES | ||
| 42 | Leflunomide | OFFSIDES | ||
| 43 | Lidoderm | OFFSIDES | ||
| 44 | Micafungin | OFFSIDES | ||
| 45 | Naloxone | OFFSIDES | ||
| 46 | Naproxen | OFFSIDES | ||
| 47 | Norepinephrine | OFFSIDES | ||
| 48 | Pancuronium | OFFSIDES | ||
| 49 | Phenprocoumon | OFFSIDES | ||
| 50 | Quinidine | OFFSIDES | ||
| 51 | Sodium Bicarbonate | OFFSIDES | ||
| 52 | Terazosin | OFFSIDES | ||
| 53 | Thioguanine | OFFSIDES | ||
| 54 | Tretinoin | OFFSIDES | ||
| 55 | carbidopa, levodopa drug combination | OFFSIDES | ||
| 56 | telithromycin | OFFSIDES |
Powered by :
Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120241
Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.